Unibest
← Back to patent-cliff list

Tranexamic acid (Leading BioSciences)

Tier C — Watch / trade

Tranexamic acid (Leading BioSciences)

Leading Biosciences Inc
Originator
-
First approval
-
Expiry (public)
No sales data
Peak sales
Small molecule
Type

Targets:PLG

Indications (approved):肠道疾病, 术后黏连, Intestinal obstruction, 胃肠疾病, COVID-19, 感染性休克, 肠梗阻

Regional status

US
Phase II
2015-04-01
EU
-
China
Phase III
2023-03-28
Japan
-

Synthetic routes & intermediates3 routes

Originator routes × 1Optimised (non-patent) × 2Process routes × 0

Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.

OriginatorRoute 1Steps 7 · Total yield 18.7 g
TRANA-001120-61-6TRANA-00242967-55-5TRANA-0037377-26-6TRANA-0046757-31-9TRANA-0051129-35-7TRANA-00620686-40-2TRANA-007—Tranexamic acid1197-18-8API · Tranexamic acid (Leading BioSciences)
CodeCAS No.Intermediate
TRANA-001120-61-6dimethyl terephthalate
TRANA-00242967-55-5potassium 4-(methoxycarbonyl)benzoate
TRANA-0037377-26-6methyl 4-(chlorocarbonyl)benzoate
TRANA-0046757-31-9methyl 4-carbamoylbenzoate
TRANA-0051129-35-7methyl 4-cyanobenzoate
TRANA-00620686-40-2methyl 4-(acetamidomethyl)benzoate
TRANA-007-methyl 4-(acetamidomethyl)cyclohexane-1-carboxylate
Tranexamic acid1197-18-8-
OptimisedRoute 2Steps 4 · Total yield /
Tranexamic acid1197-18-8TRANA-0081205-58-9TRANA-009—TRANA-01052914-91-7TRANA-01116556-65-3API · Tranexamic acid (Leading BioSciences)
CodeCAS No.Intermediate
Tranexamic acid1197-18-8-
TRANA-0081205-58-94-(acetamidomethyl)benzoic acid
TRANA-009-sodium 4-(acetamidomethyl)cyclohexane-1-carboxylate
TRANA-01052914-91-7sodium (1r,4r)-4-(aminomethyl)cyclohexane-1-carboxylate
TRANA-01116556-65-3(1r,4r)-4-(aminomethyl)cyclohexane-1-carboxylic acid compound with 4-methylbenzenesulfonic acid (1:1)
OptimisedRoute 3Steps 5 · Total yield /
TRANA-0126308-18-5TRANA-0133236-48-4TRANA-014170811-08-2TRANA-015170811-09-3TRANA-016170811-10-6API · Tranexamic acid (Leading BioSciences)
CodeCAS No.Intermediate
TRANA-0126308-18-5cyclohexane-1,4-diylbis(methylene) diacetate
TRANA-0133236-48-4((1r,4r)-cyclohexane-1,4-diyl)dimethanol
TRANA-014170811-08-2((1r,4r)-4-(hydroxymethyl)cyclohexyl)methyl 4-methylbenzenesulfonate
TRANA-015170811-09-3((1r,4r)-4-(azidomethyl)cyclohexyl)methanol
TRANA-016170811-10-6(1r,4r)-4-(azidomethyl)cyclohexane-1-carboxylic acid

Frequently asked questions

What are the approved indications of Tranexamic acid (Leading BioSciences)?

Approved indications include: 肠道疾病, 术后黏连, Intestinal obstruction, 胃肠疾病, COVID-19, 感染性休克, 肠梗阻.

When does the Tranexamic acid (Leading BioSciences) patent expire?

No public expiry year is available for Tranexamic acid (Leading BioSciences) yet; this page updates once verified.

How many synthesis routes are recorded for Tranexamic acid (Leading BioSciences)?

3 synthesis routes are recorded; the shortest is 4 steps with / total yield. Intermediates in each route carry codes and CAS numbers.

Where can I buy Tranexamic acid (Leading BioSciences) intermediates?

All intermediates in Tranexamic acid (Leading BioSciences) routes have CAS profiles — you can submit an RFQ per CAS and it enters the Unibest matching pool.

How do I get a quote for Tranexamic acid (Leading BioSciences) intermediates?

Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.

Source: cross-verified data (structured fields only) · 2026-10-05